Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01785 |
| Species: | Homo sapiens |
| Position : | chr2:60447611-60449611 |
| Year: | 2019 |
| Title: | Expression analysis data of BCL11A and ??-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | lung carcinoma |
| PMID: | 31890812 |
| MONDO: | MONDO:0005061 |
| Tissue: | Lung |
| Tissue Ontology ID: | UBERON:0002048 |
| Cell Source: | Lung carcinoma cells |
| CVCL ID: | |
| Cell Type: | lung carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer CRISPR perturbation study, Chromatin interaction assay |
| High Throughput Method: | |
| Low Throughput Method: | 3C, RT-RT-qPCR |
| Target gene : | BCL11A |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|